Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

modified

modified is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 24
News articles 0
Drug details — modified
Class
—
Route
—
Patents
20
Programs
24
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

modified is an FDA-listed pharmaceutical active ingredient.

Key facts

INN modified

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 6520-9970-08 Phase 3 · MEDICE Arzneimittel Pütter · Patients with ADHD (according to ICD-10 / DSM-5)
  2. DC 06/02 Phase 3 · Takeda · Adrenal Insufficiency
  3. 111-210 Phase 2 · BioMarin Pharmaceutical Australia · Idiopathic Short Stature (ISS)
  4. 111-211 Phase 2 · BioMarin Pharmaceutical Australia · Turner Syndrome, Short Stature Homeobox-Containing Gene Defi
  5. CB-01-33/01 Phase 2 · Cosmo Pharmaceuticals · bile acid diarrhoea (BAD)
  6. Hydrocortisone Modified Release Capsules Phase 2 · NEUROCRINE BIOSCIENCES · Endocrine Disease
  7. Modified Wenxin Decoction Phase 2 · Chinese Academy of · Heart Failure
  8. Modified-Release Prednisone Phase 2 · United Therapeutics Europe · Chronic Inflammation

Related patents

Browse patents

  1. US 12414963

    Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12410209

    Modified glucocorticoids

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12402611

    Genetically modified mice and engraftment

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12385043

    Modified double-stranded RNA agents

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12385044

    Modified double-stranded RNA agents

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12378280

    Deoxynucleic guanidines (DNG)-modified oligonucleotides and methods of synthesizing deoxynucleic guanidine strands

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12378553

    Modified double-stranded RNA agents

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12331307

    Modified immunization vectors

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12317874

    Method of using a genetically modified mouse that expresses human albumin

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12318418

    Modified adenoviruses

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12290573

    Modified RNAi agents

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12250931

    Genetically modified mouse with a humanized PNPLA3 gene and methods of use

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12252552

    Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12226403

    Tebipenem pivoxil immediate and modified release oral dosage forms

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12221622

    Modified pluripotent cells

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12215162

    BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12203072

    Chemically modified single-stranded rna-editing oligonucleotides

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12173062

    Modified TNF-α antibodies and uses thereof

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12173337

    Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12168767

    Modified double-stranded RNA agents

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is modified?

modified is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.